PLXDC1 Can Be a Biomarker for Poor Prognosis and Immune Evasion in Gastric Cancer.

Xinwei Li Yongfei FanMingyue TangHuiyuan LiYue ZhangJiaqi MiYanyan WangMenglin ZhaoZishu WangFang Su

Published in: Journal of inflammation research (2022)

This study analyzed PLXDC1 from multiple biological perspectives and revealed that PLXDC1 can be a biomarker for poor prognosis and immune evasion in gastric cancer.

Keyphrases

poor prognosis
long non coding rna
single cell